INTENSITY THERAPEUTICS, INC. (INTS)
2025-06-30 | ||||
---|---|---|---|---|
Other income, net | 151 | |||
Research and development | 1,541 | |||
General and administrative | 1,164 | |||
Total operating expenses | 2,705 | |||
Loss from operations | -2,705 | |||
Interest income | 17 | |||
Net loss | -2,537 | |||
Loss per share, basic (in dollars per share) | -0.13 | |||
Loss per share, diluted (in dollars per share) | -0.13 | |||
Weighted average number of shares of common stock, basic (in shares) | 18,868,124 | |||
Weighted average number of shares of common stock, diluted (in shares) | 18,868,124 |